Adaptimmune Ther ADR (ADAP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ADAP | BMY | AMGN | GSK | GILD |
| Company | Adaptimmune Ther ADR | Bristol-Myers Squibb Company | Amgen Inc | Gsk Plc ADR | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 1.0300 | 49.89 | 337.03 | 42.40 | 84.39 |
| High | 1.0600 | 50.04 | 338.70 | 42.42 | 84.65 |
| Low | 1.0205 | 49.11 | 334.61 | 41.46 | 83.57 |
| Last | 1.0400 | 49.27 | 336.94 | 41.87 | 84.44 |
| Change | +0.0100 | -0.47 | +4.02 | -0.56 | +0.55 |
| % Change | +0.96% | -0.94% | +1.21% | -1.32% | +0.66% |
| Volume | 521,884 | 2,513,050 | 516,538 | 3,455,965 | 2,854,213 |
| 20-Day Average Volume | 1,041,731 | 8,285,943 | 1,704,359 | 3,591,867 | 6,388,822 |
| Previous Close | 1.0400 | 49.74 | 332.92 | 42.43 | 83.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.1475 | 49.10 | 329.61 | 43.29 | 80.10 |
| 20-Day Raw Stochastic | 9.68% | 63.26% | 87.65% | 16.41% | 95.65% |
| 20-Day Relative Strength | 44.62% | 55.59% | 58.10% | 48.76% | 72.95% |
| Weighted Alpha | -20.06 | -10.42 | +27.40 | +11.40 | +19.35 |
| Today's Opinion | 24% Sell | 72% Buy | 96% Buy | 56% Buy | 88% Buy |
| Previous Opinion | 24% Sell | 72% Buy | 88% Buy | 56% Buy | 88% Buy |
| Last Month's Opinion | 8% Sell | 40% Buy | 88% Buy | 40% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.55% since 09/12/24 | +2.26% since 09/12/24 | +1.96% since 09/12/24 | -2.59% since 09/12/24 | +1.58% since 09/12/24 |
| Low | 1.0200 on 09/19/24 | 48.20 on 09/13/24 | 327.15 on 09/13/24 | 41.47 on 09/19/24 | 81.57 on 09/13/24 |
| High | 1.1650 on 09/13/24 | 50.41 on 09/17/24 | 339.00 on 09/18/24 | 43.62 on 09/16/24 | 84.61 on 09/19/24 |
| 1-Month | |||||
| %Chg | -6.25% since 08/19/24 | +0.06% since 08/19/24 | +2.61% since 08/19/24 | +1.14% since 08/19/24 | +13.47% since 08/19/24 |
| Low | 1.0200 on 09/19/24 | 46.88 on 08/22/24 | 319.00 on 09/06/24 | 41.47 on 09/19/24 | 74.34 on 08/20/24 |
| High | 1.3300 on 08/26/24 | 50.75 on 09/04/24 | 339.00 on 09/18/24 | 44.67 on 08/27/24 | 84.89 on 09/12/24 |
| 3-Month | |||||
| %Chg | +19.32% since 06/18/24 | +20.88% since 06/18/24 | +9.98% since 06/18/24 | +2.55% since 06/18/24 | +33.77% since 06/18/24 |
| Low | 0.8250 on 06/26/24 | 39.35 on 07/05/24 | 303.55 on 06/20/24 | 37.81 on 07/02/24 | 64.86 on 06/20/24 |
| High | 1.4800 on 07/30/24 | 51.19 on 07/29/24 | 346.85 on 07/25/24 | 44.67 on 08/27/24 | 84.89 on 09/12/24 |
| 6-Month | |||||
| %Chg | -25.53% since 03/19/24 | -4.77% since 03/19/24 | +23.85% since 03/19/24 | -0.77% since 03/19/24 | +15.07% since 03/19/24 |
| Low | 0.8250 on 06/26/24 | 39.35 on 07/05/24 | 260.68 on 04/19/24 | 37.81 on 07/02/24 | 62.07 on 05/31/24 |
| High | 1.6500 on 03/28/24 | 54.47 on 03/28/24 | 346.85 on 07/25/24 | 45.92 on 05/15/24 | 84.89 on 09/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 256,698 | 100,827,960 | 178,589,936 | 87,935,408 | 104,514,608 |
| Shares Outstanding, K | 246,825 | 2,027,100 | 536,435 | 2,072,482 | 1,245,853 |
| Annual Sales | 60,280,000 | 45,006,000,000 | 28,190,000,000 | 37,725,000,000 | 27,116,000,000 |
| Annual Net Income | -113,870,000 | 8,025,000,000 | 6,717,000,000 | 6,129,940,000 | 5,665,000,000 |
| Last Quarter Sales | 128,230,000 | 12,201,000,000 | 8,388,000,000 | 9,950,400,000 | 6,954,000,000 |
| Last Quarter Net Income | 69,520,000 | 1,680,000,000 | 746,000,000 | 1,480,440,000 | 1,614,000,000 |
| 60-Month Beta | 2.21 | 0.46 | 0.61 | 0.66 | 0.18 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.27 on 08/12/24 | 2.07 on 07/26/24 | 4.97 on 08/06/24 | 1.09 on 07/31/24 | 2.01 on 08/08/24 |
| Latest Earnings Date | 08/12/24 | 10/31/24 | 10/29/24 | 11/06/24 | 11/05/24 |
| Most Recent Dividend | N/A | 0.600 on 07/05/24 | 2.250 on 08/16/24 | 0.378 on 08/16/24 | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 10/04/24 | 08/16/24 | 08/16/24 | 09/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 36.12 | 17.89 | 10.23 | 17.67 |